Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT04118790
Recruiting Observational

Microstructure Imaging in Stroke Patients

NCT04118790 · tracked via the Priya Life Science Denmark tracker
Phase
Observational
Started
2019-12-23
Last updated
2022-05-26

Condition(s) studied

FatigueStroke, AcuteTransient Ischemic Attack

Investigational drug(s) / intervention(s)

Clinical AssessmentMRI scan

Clinical Assessment: 1. Medical history and details of the vascular incident will be collected from the patient and the medical journal. (Duration: 1hr) 2. Neuropsychological measures collected using test measures and questionaries (duration approx 45-60 min).

MRI scan: 1\. MRI scan session, which includes Structural, Quantitative, Functional and Diffusion MRI sequences. (maximum duration: 90 min).

Study summary

The purpose of this study is to establish a methodological framework based on existing advanced neuroimaging technologies as a new clinical neuroimaging tool for assessment of possible affected brain connections in stroke and TIA patients. Thus, providing new insights into microstructural changes that may underline why those patients experience deficits like fatigue.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Patient Inclusion Criteria: * Stroke or TIA (ABCD2\>4 and/or acute Diffusion-Weighted Image (DWI) lesion). * Modified Rankin Scale \<=2. * As perceived by the investigator, have the ability to comply with all requirements of the study protocol. * Have the ability to understand and sign the Informed Consents Form. * Multidimensional Fatigue Inventory score \>= 12 on general fatigue. Patient Exclusion Criteria: * The DRCMR´s general exclusion criteria for MRI research. * Pregnancy or lactation; human chorionic gonadotropin (hCG) urine test is offered for women \< 55 years. * Major medical illness (for instance: anemia, diabetes mellitus, thyroid disorders, cardiovascular disease, electrolyte imbalance, etc.) * Treated with ritalin or modafinil. * Known uncontrolled severe malignancy. * Known drug or alcohol addiction. * Tiredness due to pharmaceutical side effects, as identified by the Investigator. * Max body weight of 130 kg. * Persons who do not wish to be informed about abnormal findings as part of the investigations. Healthy Controls Exclusion Criteria: * The DRCMR´s general exclusion criteria for MRI research. * Pregnancy or lactation; urin hCG test is offered for women \< 55 years. * Major medical illness (for instance: anemia, diabetes mellitus, thyroid disorders, cardiovascular disease, electrolyte imbalance, etc.) * Anamnestic infection (cystitis, influenza, pneumonia, etc) the last 3 weeks. * Known malignancy. * Known drug or alcohol addiction. * Tiredness due to pharmaceutical side effects. * Max body weight of 130 kg. * Persons who do not wish to be informed about abnormal findings as part of the investigations. Healthy Controls Inclusion Criteria: * Healthy * Age- and sex-matched to patient groups. * As perceived by the investigator, have the ability to comply with all requirements of the study protocol. * Have the ability to understand and sign the Informed Consents Form.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Bispebjerg Hospital Copenhagen København NV Recruiting
Danish Research Centre for Magnetic Resonance Copenhagen Denmark Recruiting

More Danish Research Centre for Magnetic Resonance trials in Denmark

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04118790 on ClinicalTrials.gov ↗ ← All trials in Denmark